GO:0034959 endothelin maturation: Proteolytic Activation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034959 endothelin maturation is the biological process that converts inactive Big-endothelin into mature, functional endothelin peptides.
• The final activating step is proteolytic cleavage by endothelin-converting enzyme 1 (ECE1), which removes the C-terminal fragment of Big-endothelin.
• Endothelin maturation is essential for cardiovascular development, vascular tone, and neural cell differentiation.
• Dysregulated endothelin maturation contributes to pulmonary arterial hypertension, cancer progression, and preterm white matter injury.
• Key research models include ECE1 knockout and knock-in cell lines, endothelin overexpression systems, and CRISPR library screening.
• Studying this process requires combining proteomics, RNA-seq, and functional assays to track Big-endothelin processing and receptor activation.
Description
Endothelin maturation (GO:0034959) is the biological process that converts the inactive precursor Big-endothelin into the mature, biologically active endothelin peptide. Endothelins are potent vasoconstrictor peptides that also regulate cell proliferation, differentiation, and migration in multiple tissues. The maturation process is essential for the full functional capacity of endothelin, as only the mature form can activate endothelin receptors. Researchers study this process to understand how vascular tone is controlled, how developmental programs are executed, and how dysregulation contributes to diseases such as pulmonary arterial hypertension and cancer. The QuickGO definition states that endothelin maturation is the process leading to the attainment of the full functional capacity of endothelin by conversion of Big-endothelin substrate into mature endothelin. This conversion is primarily mediated by endothelin-converting enzyme 1 (ECE1), a membrane-bound metalloprotease that cleaves Big-endothelin between specific residues. Because endothelin signaling is involved in both normal physiology and numerous pathologies, understanding the maturation step is critical for therapeutic development.
endothelin maturation At A Glance
| GO ID | GO:0034959 |
|---|---|
| GO term | endothelin maturation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Proteolytic conversion of Big-endothelin to mature endothelin, enabling receptor activation and vasoactive signaling. |
| Key enzyme | Endothelin-converting enzyme 1 (ECE1). |
| Substrate | Big-endothelin (proendothelin). |
| Product | Mature endothelin-1, endothelin-2, or endothelin-3. |
| Cellular location | Secretory pathway, including Golgi and secretory vesicles. |
| Related diseases | Pulmonary arterial hypertension, cancer, preterm white matter injury. |
What Is GO:0034959?
In simple terms, endothelin maturation is the molecular trimming process that turns an inactive precursor protein into a fully functional signaling peptide. According to the QuickGO definition, it is the process leading to the attainment of the full functional capacity of endothelin by conversion of Big-endothelin substrate into mature endothelin. This process is a biological process (GO:0034959) and involves the proteolytic removal of a C-terminal fragment from Big-endothelin, yielding the mature 21-amino-acid endothelin peptide. The reaction is catalyzed by endothelin-converting enzymes, predominantly ECE1, and is a prerequisite for endothelin receptor binding and downstream signaling.
Why Is endothelin maturation Important in Cell Biology?
Endothelin maturation is critically important because it is the rate-limiting step that determines the availability of active endothelin peptides, which are among the most potent vasoconstrictors known. Without proper maturation, endothelin cannot bind to its receptors (EDNRA and EDNRB) to regulate vascular tone, cardiac development, and neuronal differentiation. Dysregulation of this process is implicated in cardiovascular diseases, cancer progression, and developmental disorders, making it a key target for therapeutic intervention and a focus of biomedical research.
• Controls the production of active endothelin peptides that regulate blood pressure and vascular tone.
• Essential for normal cardiovascular development, including cardiac organoid function.
• Plays a role in oligodendrocyte differentiation and myelination in the developing brain.
• Contributes to the pathogenesis of pulmonary arterial hypertension through excessive endothelin signaling.
• Promotes cancer progression, including ovarian cancer invadopodia formation and metastasis.
• Involved in preterm white matter injury and neonatal hypoxic-ischemic encephalopathy.
• Serves as a target for drugs like endothelin receptor antagonists, highlighting its clinical relevance.
• Provides a model for studying proteolytic processing and secretory pathway biology.
• Enables research on tissue-specific regulation of peptide hormone maturation.
• Offers opportunities for CRISPR-based functional genomics and therapeutic target discovery.
What Happens During endothelin maturation?
Transcription and translation of preproendothelin
In simple terms: The cell first makes a long inactive precursor protein called preproendothelin.
Endothelin maturation begins with the transcription and translation of the EDN1, EDN2, or EDN3 genes, producing preproendothelin, a large precursor protein. This precursor contains a signal peptide that directs it to the endoplasmic reticulum, where it undergoes initial processing. The preproendothelin is then cleaved by furin-like proteases to generate Big-endothelin, an intermediate that is biologically inactive.
Formation of Big-endothelin
In simple terms: The precursor is trimmed down to a smaller but still inactive form called Big-endothelin.
Big-endothelin is a 38- to 41-amino-acid peptide that retains the mature endothelin sequence at its N-terminus but has an extended C-terminus. This intermediate is the direct substrate for endothelin-converting enzyme 1 (ECE1). Big-endothelin can be secreted and circulate in plasma, but it lacks full functional capacity until proteolytically activated.
Proteolytic cleavage by ECE1
In simple terms: A specific enzyme called ECE1 cuts Big-endothelin to release the active endothelin peptide.
Endothelin-converting enzyme 1 (ECE1) is a membrane-bound zinc metalloprotease that cleaves Big-endothelin between Trp21 and Val22 (for endothelin-1) to produce the mature 21-amino-acid endothelin peptide. This cleavage occurs in the secretory pathway, primarily in the Golgi apparatus and secretory vesicles. ECE1 activity is essential for the generation of mature endothelin, as genetic deletion of ECE1 results in loss of mature endothelin and severe developmental defects.
Mature endothelin and receptor activation
In simple terms: The mature endothelin is now ready to bind receptors and trigger signaling.
Once mature endothelin is generated, it is secreted and can bind to endothelin receptor A (EDNRA) or endothelin receptor B (EDNRB) on target cells. This binding activates downstream signaling pathways, including Gq-mediated calcium mobilization and MAPK cascades, which regulate vasoconstriction, cell proliferation, and differentiation. In the developing brain, endothelin-1 signaling through EDNRB contributes to oligodendrocyte differentiation and myelination.
Regulation of endothelin maturation
In simple terms: The cell controls how much active endothelin is made by regulating the enzymes and precursors involved.
Endothelin maturation is regulated at multiple levels, including transcriptional control of EDN1 and ECE1, post-translational modifications of ECE1, and the availability of Big-endothelin substrate. Factors such as hypoxia, shear stress, and inflammatory cytokines can upregulate EDN1 and ECE1 expression, increasing mature endothelin production. Additionally, ECE1 activity can be modulated by pH and calcium levels within the secretory pathway. This tight regulation ensures appropriate endothelin levels for vascular homeostasis and tissue development.
Key Genes Involved in GO:0034959 endothelin maturation
The following genes and proteins are directly involved in endothelin maturation, from precursor synthesis to proteolytic activation and receptor signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EDN1 | Encodes preproendothelin-1, the precursor of endothelin-1 | Central to vascular tone regulation and cardiovascular disease models |
| EDN2 | Encodes preproendothelin-2 | Implicated in ovarian and endocrine functions |
| EDN3 | Encodes preproendothelin-3 | Involved in neural crest development and Hirschsprung disease |
| ECE1 | Endothelin-converting enzyme 1; cleaves Big-endothelin to mature endothelin | Key enzyme for maturation; knockout models show severe phenotypes |
| ECE2 | Endothelin-converting enzyme 2; related protease with broader substrate specificity | Potential compensatory or distinct roles in peptide processing |
| EDNRA | Endothelin receptor A; mediates vasoconstriction and cell proliferation | Target for pulmonary arterial hypertension therapies |
| EDNRB | Endothelin receptor B; mediates vasodilation and neural development | Linked to oligodendrocyte differentiation and white matter injury |
| FURIN | Proprotein convertase that processes preproendothelin to Big-endothelin | Involved in initial steps of endothelin maturation |
| MMP2 | Matrix metalloproteinase 2; can contribute to alternative endothelin processing | Potential role in cancer and tissue remodeling |
| YAP1 | Transcriptional co-activator that regulates EDN1 expression | Modulates endothelin-1-guided invadopodia in ovarian cancer |
| HIF1A | Hypoxia-inducible factor 1-alpha; upregulates EDN1 under hypoxia | Links hypoxia to endothelin maturation in disease |
| GATA4 | Transcription factor regulating cardiac development and EDN1 expression | Relevant to cardiac organoid and developmental studies |
| NOTCH1 | Signaling receptor that interacts with endothelin pathways in development | Context-dependent crosstalk in cardiovascular development |
| SOX10 | Neural crest transcription factor regulating EDN3 and EDNRB | Important for enteric nervous system development |
| VEGFA | Vascular endothelial growth factor A; interacts with endothelin signaling | Modulates angiogenesis and vascular permeability |
| AGT | Angiotensinogen; part of renin-angiotensin system that crosstalks with endothelin | Relevant to hypertension research |
| NOS3 | Endothelial nitric oxide synthase; counterbalances endothelin-mediated vasoconstriction | Key for vascular homeostasis studies |
How Is endothelin maturation Regulated?
Endothelin maturation is regulated primarily at the level of gene expression and enzyme activity. Hypoxia, shear stress, and cytokines such as TNF-alpha and IL-1beta upregulate EDN1 and ECE1 transcription, increasing the production of mature endothelin. The transcription factor HIF1A mediates hypoxia-induced EDN1 expression. Additionally, ECE1 activity is influenced by intracellular calcium and pH, and its trafficking through the secretory pathway is tightly controlled. Post-translational modifications, including glycosylation, affect ECE1 stability and function. In cancer, YAP signaling orchestrates endothelin-1-guided invadopodia formation, linking mechanical cues to endothelin maturation and function. In the developing brain, endothelin-1-EDNRB signaling is regulated during oligodendrocyte differentiation, and its disruption leads to myelin deficits.
endothelin maturation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EDN1 | Pulmonary arterial hypertension; vasoconstriction | Endothelial cell knockout or overexpression |
| ECE1 | Cardiovascular developmental defects; hypertension | ECE1 knockout mouse or human iPSC-derived cardiomyocytes |
| EDNRB | Preterm white matter injury; Hirschsprung disease | Oligodendrocyte precursor cell knockout |
| YAP1 | Ovarian cancer metastasis; invadopodia formation | Cancer cell line with YAP1 knockout or overexpression |
| HIF1A | Hypoxia-induced endothelin production | Hypoxia chamber with HIF1A knockdown |
Pulmonary arterial hypertension and cardiovascular disease
Excessive endothelin maturation and signaling contribute to the pathogenesis of pulmonary arterial hypertension (PAH) and other cardiovascular disorders. Elevated levels of mature endothelin-1 cause sustained vasoconstriction and vascular remodeling, leading to increased pulmonary vascular resistance. Endothelin receptor antagonists are used clinically to treat PAH, highlighting the therapeutic importance of this pathway. In cardiac organoids, endothelin signaling influences functionality, and perturbation of ligand-receptor interactions can alter cardiac state.
Cancer progression and metastasis
Endothelin-1, generated through endothelin maturation, promotes cancer cell proliferation, migration, and invasion in multiple malignancies. In high-grade serous ovarian cancer, YAP signaling orchestrates endothelin-1-guided invadopodia formation, facilitating metastasis. Endothelin receptor antagonists have been investigated as potential anti-cancer agents, though clinical results vary. The maturation step, particularly ECE1 activity, is a potential target for disrupting endothelin-driven tumor progression.
Neurodevelopmental and white matter disorders
Endothelin-1 signaling through EDNRB is critical for oligodendrocyte differentiation and myelination. Disruption of this pathway contributes to preterm white matter injury, a major cause of cerebral palsy. In neonatal hypoxic-ischemic encephalopathy, endothelin dysregulation may exacerbate brain injury, and therapies targeting this pathway are under investigation. These findings underscore the importance of precise regulation of endothelin maturation in neural development.
From endothelin maturation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ECE1 loss abolish mature endothelin production? | ECE1 knockout cell line (e.g., HEK293 or endothelial cells) |
| How does a point mutation in EDN1 affect cleavage by ECE1? | EDN1 point-mutation knock-in cell line |
| Can tagged endothelin track secretion and maturation? | EDN1 knock-in with fluorescent or epitope tag |
| What is the effect of endothelin overexpression on cancer invasion? | EDN1 overexpression in ovarian cancer cells |
| Which genes regulate endothelin maturation in cardiac organoids? | CRISPR library screening in human cardiac organoids |
| How does EDNRB signaling affect oligodendrocyte differentiation? | EDNRB knockout in oligodendrocyte precursor cells |
How to Study the endothelin maturation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Levels of Big-endothelin and mature endothelin | Validation of ECE1 knockout or knock-in |
| RNA-seq | Expression of EDN1, ECE1, and related genes | Tissue-specific regulation and disease models |
| Calcium mobilization assay | Bioactive endothelin production | Functional assessment of maturation |
| Western blot | Protein levels of ECE1 and endothelin precursors | Knockout validation and pathway analysis |
| Immunofluorescence | Subcellular localization of ECE1 and endothelin | Trafficking and secretion studies |
| CRISPR library screening | Genes required for endothelin maturation | Discovery of novel regulators |
| Organoid culture | Endothelin effects on tissue function | Cardiac and neural development |
| Invadopodia assay | Endothelin-1-driven cancer cell invasion | Ovarian cancer metastasis research |
Proteomic analysis of endothelin processing
Mass spectrometry-based proteomics can detect and quantify Big-endothelin and mature endothelin in cell lysates and conditioned media, providing direct evidence of maturation efficiency. Targeted proteomics using selected reaction monitoring (SRM) allows sensitive measurement of endothelin peptides in biological samples. These methods are essential for validating knockout or knock-in models and for studying disease-associated changes in maturation.
Transcriptomic profiling of maturation genes
RNA-seq can measure the expression of EDN1, EDN2, EDN3, ECE1, and other genes involved in endothelin maturation across different tissues and conditions. In cardiac organoids, transcriptomic profiling has revealed how vascular cells improve functionality and modulate endothelin signaling. Single-cell RNA-seq can resolve cell-type-specific expression patterns in complex tissues.
Functional assays for endothelin signaling
Endothelin maturation can be functionally assessed by measuring calcium mobilization, vasoconstriction, or reporter gene activation in response to mature endothelin. In vitro assays using endothelin receptor-expressing cells can quantify the amount of bioactive endothelin produced. These assays are critical for linking maturation to downstream physiological effects.
Imaging of endothelin trafficking and secretion
Fluorescently tagged endothelin or ECE1 can be used to visualize the secretory pathway and track maturation in live cells. Confocal microscopy and live-cell imaging reveal co-localization with Golgi markers and secretory vesicles. In cancer cells, imaging of invadopodia formation has shown how endothelin-1 guides invasive structures.
How CRISPR Can Be Used to Study GO:0034959 endothelin maturation
Knockout
CRISPR knockout of ECE1 or EDN1 in cell lines abolishes mature endothelin production, providing a clean model to study the consequences of maturation loss. Knockout of EDNRB in oligodendrocyte precursors impairs differentiation and myelination, linking maturation to neural development. These models are essential for target validation and for understanding disease mechanisms.
Point Mutation
Point mutations in the cleavage site of Big-endothelin or in the catalytic domain of ECE1 can be introduced using CRISPR base editing or homology-directed repair. Such models help dissect the precise residues required for proteolytic processing and can mimic human mutations associated with disease. For example, mutations affecting the Trp21-Val22 bond in endothelin-1 would prevent maturation.
Knock-in
Knock-in of fluorescent or epitope tags into the endogenous EDN1 locus allows real-time tracking of endothelin maturation and secretion. Tagged ECE1 knock-in enables studies of enzyme trafficking and localization. These models are valuable for high-content imaging and proteomic analyses.
Overexpression
Overexpression of EDN1 or ECE1 in cell lines or organoids increases mature endothelin production and can model pathological states such as cancer or hypertension. In ovarian cancer cells, EDN1 overexpression enhances invadopodia formation and invasion. Overexpression models are useful for gain-of-function studies and drug screening.
How EDITGENE Supports endothelin maturation Research
Researchers studying endothelin maturation-related genes often need to determine whether a candidate gene is causally involved in the processing of Big-endothelin or in downstream signaling. This requires precise genetic models that can isolate the maturation step from other pathways. EDITGENE provides a comprehensive suite of CRISPR services to generate such models efficiently and reliably.
Contact EDITGENE today to design your custom CRISPR model for endothelin maturation research.
Frequently Asked Questions About endothelin maturation
What is endothelin maturation (GO:0034959)?
Endothelin maturation is the biological process that converts inactive Big-endothelin into mature, functional endothelin peptides through proteolytic cleavage, primarily by ECE1.
What genes are involved in endothelin maturation?
Key genes include EDN1, EDN2, EDN3 (encoding precursors), ECE1 (the converting enzyme), and FURIN (for initial processing).
Which enzyme performs endothelin maturation?
Endothelin-converting enzyme 1 (ECE1) is the primary enzyme that cleaves Big-endothelin to mature endothelin.
What diseases are linked to endothelin maturation?
Dysregulated maturation is linked to pulmonary arterial hypertension, cancer progression, preterm white matter injury, and cardiovascular disorders.
How can I study endothelin maturation in the lab?
Common methods include mass spectrometry for peptide quantification, RNA-seq for gene expression, calcium mobilization assays for function, and CRISPR knockout models.
What is the role of ECE1 in endothelin maturation?
ECE1 is a membrane-bound metalloprotease that cleaves Big-endothelin between specific residues to release the mature 21-amino-acid endothelin peptide.
Can CRISPR be used to study endothelin maturation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the maturation pathway and its disease relevance.
What is Big-endothelin?
Big-endothelin is the inactive intermediate precursor of endothelin that requires proteolytic cleavage to become fully functional.
How is endothelin maturation regulated?
It is regulated by transcription factors like HIF1A, cytokines, hypoxia, and post-translational modifications of ECE1.
What cell models are available for endothelin maturation research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell lines, and CRISPR library screening services for genes in this pathway.
Conclusion
Endothelin maturation (GO:0034959) is a tightly regulated proteolytic process that converts Big-endothelin into mature, bioactive endothelin peptides, primarily through the action of ECE1. This process is essential for cardiovascular development, vascular tone, and neural differentiation, and its dysregulation contributes to major human diseases including pulmonary arterial hypertension, cancer, and white matter injury. Understanding the molecular mechanisms and regulation of endothelin maturation offers opportunities for therapeutic intervention and requires robust experimental models. EDITGENE's CRISPR services provide the tools needed to dissect this pathway with precision and efficiency.
References
- 1. Davenport AP et al.. 2006. Endothelin.. Handb Exp Pharmacol PMID: 16999223
- 2. Voges HK et al.. 2023. Vascular cells improve functionality of human cardiac organoids.. Cell Rep 42(5):112322 PMID: 37105170
- 3. Hirata Y. 1996. Endothelin peptides.. Curr Opin Nephrol Hypertens 5(1):12-5 PMID: 8834156
- 4. Kanai SM et al.. 2023. Endothelin signaling in development.. Development 150(24) PMID: 38078652
- 5. Ranjan AK et al.. 2023. Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy.. J Clin Med 12(20) PMID: 37892791
- 6. Tocci P et al.. 2024. YAP signaling orchestrates the endothelin-1-guided invadopodia formation in high-grade serous ovarian cancer.. Biosci Rep 44(12) PMID: 39495612
- 7. Reid JD et al.. 2026. Cardiopedia-Ligand: A ligand-receptor perturbation atlas of human cardiac organoid function and transcriptional state.. Cell Stem Cell 33(8):1363-1378.e9 PMID: 42520797
- 8. Du M et al.. 2023. Endothelin-1-Endothelin receptor B complex contributes to oligodendrocyte differentiation and myelin deficits during preterm white matter injury.. Front Cell Dev Biol 11:1163400 PMID: 37009471
